
NASDAQHealthcareMedical - Devices
最新資料
US$4.19
+US$0.065 · +1.58%
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
前收盤價
US$4.19
+US$0.065 · +1.58%
盤中時間採用ET。市場資料可能有所延遲。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日內區間
目前US$4.19
52週區間
目前US$4.19
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
47
合理估值
情緒
48
多空交錯
風險
33
中等風險
動能
78
動能增強
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
日內區間
目前US$4.19
52週區間
目前US$4.19
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 7074.52萬 USD | 6935.26萬 USD | 6532.42萬 USD | 5791.71萬 USD | 5208.4萬 USD |
| 銷貨成本 | 4065.14萬 USD | 4062.72萬 USD | 3893.31萬 USD | 3249.19萬 USD | 3030.95萬 USD |
| 毛利 | 3009.38萬 USD | 2872.54萬 USD | 2639.11萬 USD | 2542.52萬 USD | 2177.45萬 USD |
| 研究與開發 | 1012.82萬 USD | 910.03萬 USD | 821.22萬 USD | 604.42萬 USD | 562.39萬 USD |
| 銷售、一般及管理費用 | 4517.43萬 USD | 4257.97萬 USD | 4028.24萬 USD | 2473.05萬 USD | 1965.87萬 USD |
| 營業費用 | 5530.26萬 USD | 5167.99萬 USD | 4849.45萬 USD | 3077.46萬 USD | 2528.26萬 USD |
| 利息收入 | 25.28萬 USD | 86.1萬 USD | 141.73萬 USD | 42.46萬 USD | 1.18萬 USD |
| 利息支出 | 79.14萬 USD | 25.53萬 USD | 25.08萬 USD | 17.66萬 USD | 6.15萬 USD |
| 折舊和攤銷 | 342.66萬 USD | 280.37萬 USD | 208.11萬 USD | 172.15萬 USD | 227.06萬 USD |
| 營業利益 | −2520.88萬 USD | −2295.46萬 USD | −2210.34萬 USD | −534.95萬 USD | −350.81萬 USD |
| 淨利 | −2933.65萬 USD | −2057.14萬 USD | −2289.56萬 USD | −308.25萬 USD | 82.74萬 USD |
公司資料更新於 2026年10月11日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$9.67
上漲空間 130.79%AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。